Espen Andre Haavardsholm • 1975 • Billingstad • 6 roles

This website uses cookies to enhance the user experience.

||

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
H HAAVARDSHOLM INVEST AS	Alternate Member	1,948,696	8,595,607	33.33 % directly
E ESPEN A HAAVARDSHOLM	Holder	-	-	-
S STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND	Board Member	2,468,187	22,529,683	-
S SKANDINAVISK REVMATOLOGISK FORSKNING STI	Chairman	2,187,366	15,843,406	-
N NORSK REVMATOLOGISK FORENING	Board Member	-	-	-
O OVERLEGE JAN A PAHLES LEGAT STI Closed	Board Member	17,600	2,187,080	-

Last update: Apr 13, 2023

Related industries

1

Services
Organizations

Direct relationships

5

JS
Joachim Støren Sagen1985
STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND, OVERLEGE JAN A PAHLES LEGAT STI
SE
Stine Elisabeth Wasenius Dahl1975
STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND, OVERLEGE JAN A PAHLES LEGAT STI
ID
Ingeborg Dybvig1961
STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND, OVERLEGE JAN A PAHLES LEGAT STI
MM
Marleen Margarete Rones1969
STIFTELSEN NORSK REVMATIKER- FORBUNDS FORSKNINGSFOND, OVERLEGE JAN A PAHLES LEGAT STI
SW
Silje Watterdal Syversen1977
SKANDINAVISK REVMATOLOGISK FORSKNING STI, NORSK REVMATOLOGISK FORENING

Shares owned by Espen Andre Haavardsholm

Name	Share class	Total operating income	Total equity	Share
H HAAVARDSHOLM INVEST AS	Ordinære aksjer	1,948,696	8,595,607	33.33 % directly
V VÅR ENERGI ASA	Ordinære aksjer	8,096,000,000	560,000,000	< 0.01 % directly
G GRIEG SEAFOOD ASA	Ordinære aksjer	275,760,000	3,981,042,000	< 0.01 % directly
M MOWI ASA	Ordinære aksjer	1,887,000,000	2,856,000,000	< 0.01 % directly
N NORDIC SEMICONDUCTOR ASA	Ordinære aksjer	667,619,000	679,587,000	< 0.01 % directly
P PROTECTOR FORSIKRING ASA	Ordinære aksjer	-	-	< 0.01 % directly
A AKER BP ASA	Ordinære aksjer	10,943,000,000	11,226,000,000	< 0.01 % directly
S SELVAAG BOLIG ASA	Ordinære aksjer	85,502,000	1,980,629,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026